Sort by
Keyphrases
Triple-negative Breast Cancer
100%
Stress Hormones
100%
Hormone Receptor
100%
Polymorphism
100%
Breast Cancer
56%
ADRB2
50%
Adrenergic beta-2 Receptors
50%
Receptors Adrenergic
50%
Codon
18%
Chemotherapy
18%
Genetic Variants
12%
Immunohistochemistry
12%
Cancer Recurrence
12%
Adrenaline
12%
Noradrenaline
12%
Cancer Mortality
12%
Genetic Variation
12%
Welsh
6%
Clinically Significant
6%
Chemotherapy-induced
6%
Stressful Conditions
6%
SNP Alleles
6%
Formalin-fixed Paraffin-embedded Tissue
6%
Gene Editing
6%
Linkage Disequilibrium
6%
Cancer Cells
6%
Date of Death
6%
SNP Haplotype
6%
Cancer-related
6%
Cancer Risk
6%
Harmful Effects
6%
Tumor
6%
Patient Prognosis
6%
Tissue Bank
6%
Women with Breast Cancer
6%
Survival Status
6%
Outcome-based
6%
Patient Samples
6%
Patient's Will
6%
Cancer Treatment
6%
Patient Outcomes
6%
Receptor Expression
6%
Haplotype Frequency
6%
Medicine and Dentistry
Triple Negative Breast Cancer
100%
Hormone Receptor
100%
Stress Hormone
100%
Breast Cancer
61%
Beta 2 Adrenergic Receptor
50%
Haplotype
33%
Receptor
33%
Codon
16%
Recurrent Disease
16%
Genetic Variability
11%
Epinephrine
11%
Noradrenalin
11%
Single Nucleotide Polymorphism
11%
Genetic Variation
11%
Immunohistochemistry
11%
Cancer Recurrence
11%
Cancer Mortality
11%
Malignant Neoplasm
11%
Neoplasm
5%
Cancer Cell
5%
Receptor Expression
5%
Allele
5%
Gene Linkage Disequilibrium
5%
Cancer Therapy
5%
Clinician
5%
Biochemistry, Genetics and Molecular Biology
Hormone Receptor
100%
Beta-2 Adrenergic Receptor
50%
Haplotype
37%
Genetic Divergence
25%
Codon
18%
Norepinephrine
12%
Epinephrine
12%
Single Nucleotide Polymorphism
12%
Genetic Variation
12%
Gene Linkage Disequilibrium
6%
Genome Editing
6%
Allele
6%
Cancer Cell
6%